BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7493469)

  • 1. Is tixocortol pivalate a photoallergen?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1995 Jul; 33(1):55-6. PubMed ID: 7493469
    [No Abstract]   [Full Text] [Related]  

  • 2. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
    Lauerma AI; Tarvainen K; Forström L; Reitamo S
    Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of the results of patch tests with tixocortol pivalate.
    Dooms-Goossens A; Andersen KE; Burrows D; Camarasa JG; Ducombs G; Frosch PJ; Lachapelle JM; Lahti A; Menné T; Rycroft RJ
    Contact Dermatitis; 1989 Feb; 20(2):158. PubMed ID: 2706969
    [No Abstract]   [Full Text] [Related]  

  • 6. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 7. Contact allergy to tixocortol pivalate.
    Camarasa JG; Malet A; Serra-Baldrich E; Lluch M
    Contact Dermatitis; 1988 Aug; 19(2):147-8. PubMed ID: 3180784
    [No Abstract]   [Full Text] [Related]  

  • 8. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patch test results with tixocortol pivalate and budesonide in Germany and Austria.
    Uter W; Geier J; Richter G; Schnuch A;
    Contact Dermatitis; 2001 May; 44(5):313-4. PubMed ID: 11380156
    [No Abstract]   [Full Text] [Related]  

  • 10. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
    Mirshahpanah P; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocortisone sensitivity: a prospective study of the value of tixocortol pivalate and hydrocortisone acetate as patch test markers.
    Wilkinson SM; English JS
    Contact Dermatitis; 1991 Aug; 25(2):132-3. PubMed ID: 1935046
    [No Abstract]   [Full Text] [Related]  

  • 12. The significance of tixocortol-pivalate-positive patch tests in leg ulcer patients.
    Wilkinson M; Cartwright P; English JS
    Contact Dermatitis; 1990 Aug; 23(2):120-1. PubMed ID: 2145125
    [No Abstract]   [Full Text] [Related]  

  • 13. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of tixocortol pivalate-positive patients in intradermal and oral provocation tests.
    Räsänen L; Tuomi ML; Ylitalo L
    Br J Dermatol; 1996 Dec; 135(6):931-4. PubMed ID: 8977714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity.
    Frankild S; Lepoittevin JP; Kreilgaard B; Andersen KE
    Contact Dermatitis; 2001 Jan; 44(1):18-22. PubMed ID: 11156006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoallergic contact dermatitis from lavender oil in topical ketoprofen.
    Goiriz R; Delgado-Jiménez Y; Sánchez-Pérez J; García-Diez A
    Contact Dermatitis; 2007 Dec; 57(6):381-2. PubMed ID: 17988288
    [No Abstract]   [Full Text] [Related]  

  • 19. Probable active sensitization to tixocortol pivalate.
    Goldsmith PC; White IR; Rycroft RJ; McFadden JP
    Contact Dermatitis; 1995 Dec; 33(6):429. PubMed ID: 8706404
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig.
    Bruze M; Bjorkner B; Dooms-Goossens A
    Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.